The First Hospital of Qinhuangdao City
Welcome,         Profile    Billing    Logout  
 5 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wu, Xiaohong
NCT05089942: Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

Not yet recruiting
4
16
RoW
Recombinant Human Insulin Patch ZJSRM2021, Placebo
Zhejiang Provincial People's Hospital
type1diabetes, Type2 Diabetes
12/21
12/22
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

Recruiting
3
424
RoW
Victoza®., Metformin Hydrochloride, TQZ2451
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Type 2 Diabetes
12/21
12/21
NCT04504396: Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Completed
3
620
RoW
GLP-1 receptor agonist, Placebo, PB-119 Placebo
PegBio Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
09/22
05/23
TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

Active, not recruiting
3
531
RoW
JS001, Nab-Paclitaxel, Placebo
Shanghai Junshi Bioscience Co., Ltd.
Triple-Negative Breast Cancer
12/24
12/25
TRIUMPH-4, NCT05931367: A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Active, not recruiting
3
405
Europe, Canada, US, RoW
Retatrutide, LY3437943, Placebo
Eli Lilly and Company
Obesity, Overweight, Osteo Arthritis Knee
02/26
03/26
NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Not yet recruiting
2
318
RoW
HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Type 2 Diabetes
04/25
04/25
NCT04866667: Observational Study of ASCVD Risks of Type 2 Diabetes in East China

Not yet recruiting
N/A
800
NA
Zhejiang Provincial People's Hospital, Zhejiang Provence Preventive Medicine Association, Ningbo Medical Center Lihuili Hospital, Affiliated Cixi Hospital of Wenzhou Medical University, Putuo People's Hospital, The Second People's Hospital of Yuhuan, Wenling People's Hospital, ShuGuang Hospital, The First People's Hospital of Jiaxing, Nanxun People's Hospital, First People's Hospital Affiliated to Huzhou University, Lishui Hospital of TCM, Hangzhou hospital of Chinese Traditional Medicine, Zhejiang Greentown Cardiovascular Hospital, Red Cross Hospital of Hangzhou, The Second School of Medicine，WMU, The First People's Hospital of Xiaoshan, Zhejiang Xiaoshan hospital, Yiwu Central Hospital, Quzhou Hospital, Jinhua Hospital of TCM, Shaoxing Central Hospital, Shaoxinig Second Hospital, Huamei hospital, University of Chinese Academy of Sciences
Type 2 Diabetes Mellitus, Arteriosclerotic Cardiovascular Disease, Liraglutide
12/23
12/24
NCT05498974: China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

Recruiting
N/A
20000
RoW
Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center
Second Xiangya Hospital of Central South University
Type1diabetes, Diabetes
12/35
12/35

Download Options